Fluticasone Propionate Patent Expiration

Fluticasone Propionate was first introduced by Fougera Pharmaceuticals Inc in its drug Cutivate on Dec 14, 1990. Other drugs containing Fluticasone Propionate are Flovent Diskus 100, Armonair Digihaler, Flonase, Flovent, Xhance, Flovent Diskus 250, Armonair Respiclick, Flonase Allergy Relief, Flovent Hfa, Flovent Diskus 50. 18 different companies have introduced drugs containing Fluticasone Propionate.


Fluticasone Propionate Patents

Given below is the list of patents protecting Fluticasone Propionate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Armonair Digihaler US11266796

(Pediatric)

Inhalation device with integrated electronics Aug 22, 2041 Teva Pharm
Armonair Digihaler US11266796 Inhalation device with integrated electronics Feb 22, 2041 Teva Pharm
Armonair Digihaler US11173259

(Pediatric)

Drug delivery device with electronics and power management Jan 06, 2041 Teva Pharm
Armonair Digihaler US11464923

(Pediatric)

Inhaler system Dec 19, 2040 Teva Pharm
Armonair Digihaler US11439777

(Pediatric)

Drug delivery device with electronics Nov 24, 2040 Teva Pharm
Armonair Digihaler US11173259 Drug delivery device with electronics and power management Jul 06, 2040 Teva Pharm
Armonair Digihaler US11464923 Inhaler system Jun 19, 2040 Teva Pharm
Armonair Digihaler US11439777 Drug delivery device with electronics May 24, 2040 Teva Pharm
Armonair Digihaler US11344685

(Pediatric)

Drug delivery device with electronics Mar 26, 2040 Teva Pharm
Armonair Digihaler US11969544

(Pediatric)

Inhalers and airflow adaptors therefor Feb 20, 2040 Teva Pharm
Armonair Respiclick US11969544

(Pediatric)

Inhalers and airflow adaptors therefor Feb 20, 2040 Teva Pharm
Armonair Digihaler US11344685 Drug delivery device with electronics Sep 26, 2039 Teva Pharm
Armonair Digihaler US11969544 Inhalers and airflow adaptors therefor Aug 20, 2039 Teva Pharm
Armonair Respiclick US11969544 Inhalers and airflow adaptors therefor Aug 20, 2039 Teva Pharm
Armonair Digihaler US11000653

(Pediatric)

Inhaler Jun 18, 2039 Teva Pharm
Armonair Digihaler US11357935

(Pediatric)

Drug delivery device with electronics Mar 24, 2039 Teva Pharm
Armonair Digihaler US11000653 Inhaler Dec 18, 2038 Teva Pharm
Armonair Digihaler US11357935 Drug delivery device with electronics Sep 24, 2038 Teva Pharm
Armonair Digihaler US11351317

(Pediatric)

Drug delivery device with electronics Aug 10, 2038 Teva Pharm
Armonair Digihaler US11351317 Drug delivery device with electronics Feb 10, 2038 Teva Pharm
Armonair Digihaler US10569034

(Pediatric)

Compliance monitoring module for a breath-actuated inhaler Feb 16, 2037 Teva Pharm
Armonair Digihaler US10569034 Compliance monitoring module for a breath-actuated inhaler Aug 16, 2036 Teva Pharm
Armonair Digihaler US10918816

(Pediatric)

Compliance monitoring module for a breath-actuated inhaler Jun 14, 2036 Teva Pharm
Armonair Digihaler US9782550

(Pediatric)

Compliance monitoring module for a breath-actuated inhaler Feb 28, 2036 Teva Pharm
Armonair Digihaler US9782551

(Pediatric)

Compliance monitoring module for a breath-actuated inhaler Feb 28, 2036 Teva Pharm
Xhance US11554229 Nasal administration Feb 23, 2036 Optinose Us Inc
Armonair Digihaler US10918816 Compliance monitoring module for a breath-actuated inhaler Dec 14, 2035 Teva Pharm
Armonair Respiclick US10918816 Compliance monitoring module for a breath-actuated inhaler Dec 14, 2035 Teva Pharm
Armonair Digihaler US9782550 Compliance monitoring module for a breath-actuated inhaler Aug 28, 2035 Teva Pharm
Armonair Digihaler US9782551 Compliance monitoring module for a breath-actuated inhaler Aug 28, 2035 Teva Pharm
Xhance US10300229 Nasal delivery devices Jul 07, 2035 Optinose Us Inc
Xhance US10076614 Nasal delivery devices Oct 20, 2034 Optinose Us Inc
Xhance US10478574 Nasal administration Nov 04, 2033 Optinose Us Inc
Xhance US10179216 Nasal delivery devices Jul 08, 2033 Optinose Us Inc
Xhance US11033696 Nasal delivery devices May 20, 2033 Optinose Us Inc
Armonair Digihaler US8714149

(Pediatric)

Airflow adaptor for a breath-actuated dry powder inhaler Aug 25, 2032 Teva Pharm
Armonair Respiclick US8714149

(Pediatric)

Airflow adaptor for a breath-actuated dry powder inhaler Aug 25, 2032 Teva Pharm
Armonair Digihaler US8978966

(Pediatric)

Dose counters for inhalers, inhalers and methods of assembly thereof Jul 13, 2032 Teva Pharm
Armonair Respiclick US8978966

(Pediatric)

Dose counters for inhalers, inhalers and methods of assembly thereof Jul 13, 2032 Teva Pharm
Armonair Digihaler US10561808

(Pediatric)

Dose counter for inhaler having an anti-reverse rotation actuator Jul 01, 2032 Teva Pharm
Armonair Respiclick US10561808

(Pediatric)

Dose counter for inhaler having an anti-reverse rotation actuator Jul 01, 2032 Teva Pharm
Armonair Digihaler US8714149 Airflow adaptor for a breath-actuated dry powder inhaler Feb 25, 2032 Teva Pharm
Armonair Respiclick US8714149 Airflow adaptor for a breath-actuated dry powder inhaler Feb 25, 2032 Teva Pharm
Armonair Digihaler US8978966 Dose counters for inhalers, inhalers and methods of assembly thereof Jan 13, 2032 Teva Pharm
Armonair Respiclick US8978966 Dose counters for inhalers, inhalers and methods of assembly thereof Jan 13, 2032 Teva Pharm
Armonair Digihaler US10561808 Dose counter for inhaler having an anti-reverse rotation actuator Jan 01, 2032 Teva Pharm
Armonair Respiclick US10561808 Dose counter for inhaler having an anti-reverse rotation actuator Jan 01, 2032 Teva Pharm
Armonair Digihaler US9216260

(Pediatric)

Dose counters for inhalers, inhalers and methods of assembly thereof Dec 28, 2031 Teva Pharm
Armonair Respiclick US9216260

(Pediatric)

Dose counters for inhalers, inhalers and methods of assembly thereof Dec 28, 2031 Teva Pharm
Armonair Digihaler US10022510

(Pediatric)

Dose counters for inhalers, inhalers and methods of assembly thereof Nov 18, 2031 Teva Pharm
Armonair Digihaler US10124131

(Pediatric)

Dose counter for inhaler having an anti-reverse rotation actuator Nov 18, 2031 Teva Pharm
Armonair Digihaler US9731087

(Pediatric)

Dose counter for inhaler having a bore and shaft arrangement Nov 18, 2031 Teva Pharm
Armonair Respiclick US10022510

(Pediatric)

Dose counters for inhalers, inhalers and methods of assembly thereof Nov 18, 2031 Teva Pharm
Armonair Respiclick US10124131

(Pediatric)

Dose counter for inhaler having an anti-reverse rotation actuator Nov 18, 2031 Teva Pharm
Armonair Respiclick US9731087

(Pediatric)

Dose counter for inhaler having a bore and shaft arrangement Nov 18, 2031 Teva Pharm
Armonair Digihaler US10195375

(Pediatric)

Airflow adaptor for a breath-actuated dry powder inhaler Aug 14, 2031 Teva Pharm
Armonair Respiclick US10195375

(Pediatric)

Airflow adaptor for a breath-actuated dry powder inhaler Aug 14, 2031 Teva Pharm
Armonair Digihaler US9216260 Dose counters for inhalers, inhalers and methods of assembly thereof Jun 28, 2031 Teva Pharm
Armonair Respiclick US9216260 Dose counters for inhalers, inhalers and methods of assembly thereof Jun 28, 2031 Teva Pharm
Armonair Digihaler US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Teva Pharm
Armonair Digihaler US10124131 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Pharm
Armonair Digihaler US9731087 Dose counter for inhaler having a bore and shaft arrangement May 18, 2031 Teva Pharm
Armonair Respiclick US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Teva Pharm
Armonair Respiclick US10124131 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Pharm
Armonair Respiclick US9731087 Dose counter for inhaler having a bore and shaft arrangement May 18, 2031 Teva Pharm
Armonair Digihaler US8714149

(Pediatric)

Airflow adaptor for a breath-actuated dry powder inhaler May 08, 2031 Teva Pharm
Xhance US12083270 Delivery device and method Apr 04, 2031 Optinose Us Inc
Armonair Digihaler US10195375 Airflow adaptor for a breath-actuated dry powder inhaler Feb 14, 2031 Teva Pharm
Armonair Respiclick US10195375 Airflow adaptor for a breath-actuated dry powder inhaler Feb 14, 2031 Teva Pharm
Xhance US10252010 Nasal delivery devices Feb 07, 2031 Optinose Us Inc
Xhance US8978647 Nasal delivery Dec 06, 2030 Optinose Us Inc
Armonair Digihaler US8714149 Airflow adaptor for a breath-actuated dry powder inhaler Nov 08, 2030 Teva Pharm
Xhance US8550073 Nasal delivery Oct 22, 2029 Optinose Us Inc
Xhance US10076615 Nasal delivery Jul 30, 2029 Optinose Us Inc
Xhance US11602603 Nasal delivery devices Oct 27, 2028 Optinose Us Inc
Armonair Digihaler US8651103

(Pediatric)

Dry powder inhalation apparatus Sep 26, 2028 Teva Pharm
Armonair Respiclick US8651103

(Pediatric)

Dry powder inhalation apparatus Sep 26, 2028 Teva Pharm
Armonair Digihaler US8651103 Dry powder inhalation apparatus Mar 26, 2028 Teva Pharm
Armonair Respiclick US8651103 Dry powder inhalation apparatus Mar 26, 2028 Teva Pharm
Xhance US10124132 Nasal delivery Mar 06, 2027 Optinose Us Inc
Flovent Hfa US7500444

(Pediatric)

Actuation indicator for a dispensing device Aug 26, 2026 Glaxo Grp Ltd
Flovent Hfa US7500444 Actuation indicator for a dispensing device Feb 26, 2026 Glaxo Grp Ltd
Xhance US7975690 Nasal devices Dec 29, 2025 Optinose Us Inc
Armonair Digihaler US10765820

(Pediatric)

Dry powder inhalation apparatus Nov 19, 2025 Teva Pharm
Armonair Digihaler US9463288

(Pediatric)

Dry powder inhalation apparatus Nov 19, 2025 Teva Pharm
Armonair Respiclick US10765820

(Pediatric)

Dry powder inhalation apparatus Nov 19, 2025 Teva Pharm
Armonair Respiclick US9463288

(Pediatric)

Dry powder inhalation apparatus Nov 19, 2025 Teva Pharm
Flovent Hfa US7500444

(Pediatric)

Actuation indicator for a dispensing device Jul 04, 2025 Glaxo Grp Ltd
Armonair Digihaler US10765820 Dry powder inhalation apparatus May 19, 2025 Teva Pharm
Armonair Digihaler US9463288 Dry powder inhalation apparatus May 19, 2025 Teva Pharm
Armonair Respiclick US10765820 Dry powder inhalation apparatus May 19, 2025 Teva Pharm
Armonair Respiclick US9463288 Dry powder inhalation apparatus May 19, 2025 Teva Pharm
Armonair Digihaler US9616024

(Pediatric)

Process for preparing a medicament Mar 01, 2025 Teva Pharm
Armonair Respiclick US9616024

(Pediatric)

Process for preparing a medicament Mar 01, 2025 Teva Pharm
Flovent Hfa US7500444 Actuation indicator for a dispensing device Jan 04, 2025 Glaxo Grp Ltd
Armonair Digihaler US9616024 Process for preparing a medicament Sep 01, 2024

(Expired)

Teva Pharm
Armonair Respiclick US9616024 Process for preparing a medicament Sep 01, 2024

(Expired)

Teva Pharm
Xhance US8522778 Nasal devices Apr 20, 2024

(Expired)

Optinose Us Inc
Flovent Hfa US7832351

(Pediatric)

Actuation indicator for a dispensing device Dec 19, 2023

(Expired)

Glaxo Grp Ltd
Armonair Digihaler US7540282

(Pediatric)

Reservoir pressure system for medicament inhaler Nov 06, 2023

(Expired)

Teva Pharm
Armonair Respiclick US7540282

(Pediatric)

Reservoir pressure system for medicament inhaler Nov 06, 2023

(Expired)

Teva Pharm
Xhance US8327844 Nasal delivery method Oct 24, 2023

(Expired)

Optinose Us Inc
Flovent Hfa US7832351 Actuation indicator for a dispensing device Jun 19, 2023

(Expired)

Glaxo Grp Ltd
Armonair Digihaler US7540282 Reservoir pressure system for medicament inhaler May 06, 2023

(Expired)

Teva Pharm
Armonair Respiclick US7540282 Reservoir pressure system for medicament inhaler May 06, 2023

(Expired)

Teva Pharm
Flovent Hfa US6743413

(Pediatric)

Suspension aerosol formulations Dec 01, 2021

(Expired)

Glaxo Grp Ltd
Armonair Digihaler US6701917 Dose counter for medicament inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Digihaler US6718972 Dose metering system for medicament inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Digihaler US6748947 De-agglomerator for breath-actuated dry powder inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Digihaler US6871646 De-agglomerator for breath-actuated dry powder inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Digihaler US8006690 Reservoir pressure system for medicament inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Respiclick US6701917 Dose counter for medicament inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Respiclick US6718972 Dose metering system for medicament inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Respiclick US6748947 De-agglomerator for breath-actuated dry powder inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Respiclick US6871646 De-agglomerator for breath-actuated dry powder inhaler Jun 23, 2021

(Expired)

Teva Pharm
Armonair Respiclick US8006690 Reservoir pressure system for medicament inhaler Jun 23, 2021

(Expired)

Teva Pharm
Flovent Hfa US6743413 Suspension aerosol formulations Jun 01, 2021

(Expired)

Glaxo Grp Ltd
Xhance US9072857 Nasal delivery device Apr 10, 2021

(Expired)

Optinose Us Inc
Flovent Hfa US9861771 Device housing for an aerosol container Oct 11, 2020

(Expired)

Glaxo Grp Ltd
Xhance US6715485 Nasal delivery device Sep 03, 2020

(Expired)

Optinose Us Inc
Xhance US9468727 Nasal delivery Jul 30, 2020

(Expired)

Optinose Us Inc
Xhance US8555878 Nasal delivery device Mar 20, 2020

(Expired)

Optinose Us Inc
Flovent Hfa US7107986

(Pediatric)

Dispenser with doses' counter Dec 08, 2019

(Expired)

Glaxo Grp Ltd
Cutivate US7300669 Fluticasone lotion having improved vasoconstrictor activity Oct 20, 2019

(Expired)

Fougera Pharms
Flovent Hfa US7350676

(Pediatric)

Valve for aerosol container Feb 24, 2019

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6431168

(Pediatric)

Dispenser with doses′ counter Dec 08, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US7350676 Valve for aerosol container Aug 24, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6161724

(Pediatric)

Indicating device Jul 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6435372

(Pediatric)

Delivery system for a medicament and method for the assembly thereof Jul 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6938796

(Pediatric)

Indicating device Jul 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6997349

(Pediatric)

Indicating device Jul 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US7143908

(Pediatric)

Indicating device Jul 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6170717

(Pediatric)

Valve for aerosol container Jun 23, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6315173

(Pediatric)

Valve for aerosol container Jun 23, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6510969

(Pediatric)

Valve for aerosol container Jun 23, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6966467

(Pediatric)

Valve for aerosol container Jun 23, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6431168 Dispenser with doses′ counter Jun 08, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US7107986 Dispenser with doses' counter Jun 08, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6161724 Indicating device Jan 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6435372 Delivery system for a medicament and method for the assembly thereof Jan 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6938796 Indicating device Jan 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6997349 Indicating device Jan 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US7143908 Indicating device Jan 16, 2018

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6170717 Valve for aerosol container Dec 23, 2017

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6315173 Valve for aerosol container Dec 23, 2017

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6510969 Valve for aerosol container Dec 23, 2017

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6966467 Valve for aerosol container Dec 23, 2017

(Expired)

Glaxo Grp Ltd
Armonair Respiclick US6446627 Inhaler dose counter Dec 18, 2017

(Expired)

Teva Pharm
Flovent Diskus 100 US5873360

(Pediatric)

Inhalation device Aug 23, 2016

(Expired)

Glaxo Grp Ltd
Flovent Diskus 250 US5873360

(Pediatric)

Inhalation device Aug 23, 2016

(Expired)

Glaxo Grp Ltd
Flovent Diskus 50 US5873360

(Pediatric)

Inhalation device Aug 23, 2016

(Expired)

Glaxo Grp Ltd
Flovent Diskus 100 US5873360 Inhalation device Feb 23, 2016

(Expired)

Glaxo Grp Ltd
Flovent Diskus 250 US5873360 Inhalation device Feb 23, 2016

(Expired)

Glaxo Grp Ltd
Flovent Diskus 50 US5873360 Inhalation device Feb 23, 2016

(Expired)

Glaxo Grp Ltd
Flovent Hfa US5674472

(Pediatric)

Canisters containing aerosol formulations containing P134a and fluticasone propionate Apr 07, 2015

(Expired)

Glaxo Grp Ltd
Flovent Hfa US5658549

(Pediatric)

Aerosol formulations containing propellant 134a and fluticasone propionate Feb 19, 2015

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6596260

(Pediatric)

Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol Feb 10, 2015

(Expired)

Glaxo Grp Ltd
Flovent Hfa US5674472 Canisters containing aerosol formulations containing P134a and fluticasone propionate Oct 07, 2014

(Expired)

Glaxo Grp Ltd
Flovent Hfa US5658549 Aerosol formulations containing propellant 134a and fluticasone propionate Aug 19, 2014

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol Aug 10, 2014

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6251368

(Pediatric)

Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant Jun 04, 2013

(Expired)

Glaxo Grp Ltd
Flovent Hfa US6251368 Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant Dec 04, 2012

(Expired)

Glaxo Grp Ltd



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fluticasone Propionate's patents.

Given below is the list recent legal activities going on the following patents of Fluticasone Propionate.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 10 Jun, 2024 US9468727
Expire Patent 14 Aug, 2023 US9072857
Recordation of Patent Grant Mailed 14 Mar, 2023 US11602603
Patent Issue Date Used in PTA Calculation 14 Mar, 2023 US11602603
Maintenance Fee Reminder Mailed 27 Feb, 2023 US9072857
Email Notification 23 Feb, 2023 US11602603
Issue Notification Mailed 22 Feb, 2023 US11602603
Application Is Considered Ready for Issue 15 Feb, 2023 US11602603
Dispatch to FDC 15 Feb, 2023 US11602603
Issue Fee Payment Received 14 Feb, 2023 US11602603


Fluticasone Propionate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fluticasone Propionate Generic API Manufacturers

Several generic applications have been filed for Fluticasone Propionate. The first generic version for Fluticasone Propionate was by Padagis Israel Pharmaceuticals Ltd and was approved on May 14, 2004. And the latest generic version is by Aurobindo Pharma Ltd and was approved on May 10, 2024.

Given below is the list of companies who have filed for Fluticasone Propionate generic, along with the locations of their manufacturing plants worldwide.


1. APOTEX

Apotex Inc has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Over the counter NASAL N/A Feb 29, 2016


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Etobicoke Apotex, Inc.
Toronto Apotex Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Brantford Apotex Pharmachem Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre





2. APOTEX INC

Apotex Inc Richmond Hill has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Prescription NASAL AB Sep 12, 2007


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
North York Apotex Inc.





3. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Over the counter NASAL N/A May 10, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





4. BRIGHT

Bright Future Pharmaceutical Laboratories Ltd has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Bright.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005%

ointment Discontinued TOPICAL N/A Sep 1, 2023


Manufacturing Plant Locations
New

Bright's manufacturing plants are situated in 6 countries - United States, Hong Kong SAR, China, Thailand, United Kingdom, Malaysia. Given below are the details of these plant locations as well as the firm names of Bright as present at those locations.

Country City Firm Name
United States
Whiteville Brights Sandwich Shop Mrs
Salem Brightwell Distributing
Woodland Bright People Foods
Burlington Brightonwoods Orchard, Inc.
New Albany Bright Innovations Labs
Littleton Brighton Commission Company
Orchard Park Brighton International Products Corp
Savannah Brighter Day
Temecula BRIGHTWATER MEDICAL, INC.
Springfield Bright Oak Meats Inc
Hood River Bright Pharma Caps Inc
Charlotte Brightwater Seafood
Nashville Brightside Bakeshop
Minneapolis Bright Research Partners
Las Vegas Brighton Laboratory
Canoga Park Bright Supply Inc
Arcadia Brighton Dairy # 1
Somerset Brightech International LLC
Santa Clarita Bright Innovation Labs
Salt Lake City Bright Eye Bakery, LLC
Hong Kong SAR
Yuen Long Bright Future Pharmaceutical Laboratories Ltd
China
Changzhou Brightness Medical Devices Co., Ltd
Suzhou BrightGene Pharmaceutical Co., Ltd.
Taizhou BrightGene Fine Chemical Co., Ltd (Tongyuan Road)
Thailand
Muang Samut Sakhon Bright Sea Co., Ltd.
United Kingdom
Nottinghamshire BRIGHTWAKE LTD
Malaysia
Klang Brightway Holdings SDN BHD





5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Prescription NASAL AB Jan 9, 2012





6. COSETTE

Cosette Pharmaceuticals Inc has filed for 2 different strengths of generic version for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005%

ointment Prescription TOPICAL AB Mar 3, 2006
0.05%

cream Prescription TOPICAL AB Jun 30, 2006


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
South Plainfield Cosette Pharmaceuticals, Inc.
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC





7. ENCUBE

Encube Ethicals Private Ltd has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Encube.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

cream Discontinued TOPICAL N/A May 14, 2004


Manufacturing Plant Locations
New

Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.

Country City Firm Name
India
Andheri East, Mumbai Encube Ethicals Private Ltd
Ponda Encube Ethicals Pvt. Ltd.





8. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 2 different strengths of generic version for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005%

ointment Discontinued TOPICAL N/A May 14, 2004
0.05%

cream Prescription TOPICAL AB May 14, 2004





9. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

(reference standard)

lotion Prescription TOPICAL AB May 2, 2011





10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05MG/SPRAY

spray, metered Discontinued NASAL N/A Apr 17, 2019


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Eatontown Hikma Pharmaceuticals USA, Inc.
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





11. NESHER PHARMS

Nesher Pharmaceuticals Usa Llc has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Nesher Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

cream Discontinued TOPICAL N/A Sep 10, 2004





12. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

lotion Prescription TOPICAL AB Jul 30, 2013
0.005%

(reference standard)

ointment Prescription TOPICAL AB May 14, 2004


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





13. TARO PHARM INDS

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Fluticasone Propionate. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.005%

ointment Discontinued TOPICAL N/A Jun 14, 2005